Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods

European Radiology

Volumn 19, Issue 8, 2009, Pages 2033-2040

  d'Assignies, Gaspard ^a   Ruel, Martin ^a   Khiat, Abdesslem ^a   Lepanto, Luigi ^a   Chagnon, Miguel ^b   Kauffmann, Claude ^a   Tang, An ^a   Gaboury, Louis ^a   Boulanger, Yvan ^c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Fat quantitation; Histopathology; Liver steatosis; Magnetic resonance spectroscopy; MRI

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BIOASSAY; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ADULT; AGED; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; FATTY LIVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 67650882236     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1351-4     Document Type: Article

References (26)

1. Yan E, Durazo F, Tong M et al (2007) Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr Rev 65:376-384
2. Yeh MM, Brunt EM (2007) Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 128:837-847
3. Schindhelm RK, Diamant M, Heine RJ (2007) Nonalcoholic fatty liver disease and cardiovascular disease risk. Curr Diab Rep 7:181-187
4. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 43:S99-S112
5. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
6. Castera L, Negre I, Samii K et al (1999) Pain experienced during percutaneous liver biopsy. Hepatology 30:1529-1530
7. Joy D, Thava VR, Scott BB (2003) Diagnosis of fatty liver disease: Is biopsy necessary? Eur J Gastroenterol Hepatol 15:539-543
8. Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898-1906
9. Vos MB, McClain CJ (2008) Nutrition and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 10:308-315
10. Te Sligte K, Bourass I, Sels JP et al (2004) Non-alcoholic steatohepatitis: Review of a growing medical problem. Eur J Intern Med 15:10-21
11. Canbakan B, Senturk H, Tahan V et al (2007) Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Acta Gastroenterol Belg 70:277-284
12. Zafrani ES (2004) Non-alcoholic fatty liver disease: An emerging pathological spectrum. Virchows Arch 444:3-12
13. Charatcharoenwitthaya P, Lindor KD (2007) Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 11:37-54 viii
14. Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462-E468
15. Hussain HK, Chenevert TL, Londy FJ et al (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 237:1048-1055
16. Bydder M, Yokoo T, Hamilton G et al (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26:347-359
17. Thomsen C, Becker U, Winkler K et al (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495
18. Nakae I, Mitsunami K, Omura T et al (2003) Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42:1587-1593
19. Longo R, Pollesello P, Ricci C et al (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281-285
20. Kim H, Taksali SE, Dufour S et al (2008) Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med 59:521-527
21. Marsman H, Matsushita T, Dierkhising R et al (2004) Assessment of donor liver steatosis: Pathologist or automated software? Hum Pathol 35:430-435
22. Promrat K, Lutchman G, Kleiner DE et al (2003) Pilot study of pioglitazone in nonalcoholic steatohepatitis. Gastroenterology 124:A-708
23. Perkins JD (2006) Saying "yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Liver Transplant 12:1012-1013
24. Cotler SJ, Guzman G, Layden-Almer J et al (2007) Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging 25:743-748
25. Boulanger Y, Amara M, Lepanto L et al (2003) Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 16:132-136
26. Irwan R, Edens MA, Sijens PE (2008) Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 18:806-813